Literature DB >> 28883139

Complete Genome Sequences of Four Extensively Drug-Resistant Pseudomonas aeruginosa Strains, Isolated from Adults with Ventilator-Associated Pneumonia at a Tertiary Referral Hospital in Mexico City.

Luis F Espinosa-Camacho1, Gabriela Delgado1, Gloria Soberón-Chávez2, Luis D Alcaraz3, Jorge Castañon4, Rosario Morales-Espinosa5.   

Abstract

Four extensively drug-resistant Pseudomonas aeruginosa strains, isolated from patients with pneumonia, were sequenced using PacBio RS-II single-molecule real-time (SMRT) technology. Genome sequence analysis identified great variability among mobile genetic elements, as well as some previously undescribed genomic islands and new variants of class 1 integrons (In1402, In1403, In1404, and In1408).
Copyright © 2017 Espinosa-Camacho et al.

Entities:  

Year:  2017        PMID: 28883139      PMCID: PMC5589533          DOI: 10.1128/genomeA.00925-17

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Pseudomonas aeruginosa is a Gram-negative bacterium and is considered to be an opportunistic human pathogen associated with infections in immunocompromised patients. The presence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains is associated with high mortality in patients with chronic infections (1, 2). Here, we present the complete genome sequences of four P. aeruginosa strains (Pa58, Pa84, Pa124, and Pa127), all isolated from adult patients with pneumonia associated with the use of automatic ventilators in an intensive care unit at a tertiary referral hospital in Mexico City. Strains Pa58, Pa124, and Pa127 were resistant to different β-lactams, including carbapenems, as well as aminoglycosides and fluoroquinolones. Strain Pa84 was resistant to only imipenem, ciprofloxacin, and levofloxacin. All of the strains were susceptible to polymyxin B. Two strains belong to sequence type 309 (ST-309), a high-risk clone previously documented in Mexico (3). The genomic DNA of the strains was purified with the DNeasy blood and tissue kit (Qiagen) and sent to the Yale Center for Genome Analysis for PacBio RS-II single-molecule real-time (SMRT) sequencing. A standard library of 20-kb fragments was prepared and sequenced on four SMRT cells with the P4-C2 chemistry. The continuous long reads were assembled using the HGAP/Quiver protocol in SMART portal version 3 (4). The genome features are described in Table 1.
TABLE 1 

Genome features and accession numbers of four P. aeruginosa strains

General composition of genomeData for strain:
Pa58Pa84Pa124Pa127
Sequence type308No data309309
No. of contigs21413
Coverage (×)∼83∼89∼91∼91
Genome size (bp)7,241,5756,566,7247,008,5167,148,302
G+C content (%)65.8066.2365.8465.74
No. of coding sequences (total)6,9276,2026,6176,777
No. of tRNAs63636363
No. of rRNA operons4 (5S, 16S, 23S)4 (5S, 16S, 23S)4 (5S, 16S, 23S)4 (5S, 16S, 23S)
No. of noncoding RNAs4544
No. of pseudogenes (total)244139131205
No. of genomic islands5333
No. of prophages128109
No. of integrative plasmids3022
No. of CRISPR-Cas arrays1200
Class 1 integron(s)In51, In173, In1212, In1403, and In1404In1402In1408
Nucleotide accession no.CP021775CP021999CP021774CP022000
Biosample accession no.SAMN05020321SAMN05020322SAMN05020323SAMN05020324
Genome features and accession numbers of four P. aeruginosa strains The sequences were annotated using the NCBI Prokaryotic Genome Annotation Pipeline (http://www.ncbi.nlm.nih.gov). The annotation was manually curated, and the genomes were analyzed for the presence of mobile elements (Table 1), antibiotic resistances genes, efflux pumps, and potential virulence factors using the IslandPath-DIMOB, SIGI-HMM, IslandPick (5), CARD (6), VirulenceFinder (7), and Integral (8) databases. All of the strains have a core genome size averaging 6.15 Mb, with a variable accessory genome. The strains presented different islands inserted at previosly described loci (9). However, these islands present a different gene composition and size than those of the previously reported PAGI-1, PAPI-2, PAGI-4, and pKLC102 strains (10–12). Strains Pa58, Pa124, and Pa127 presented a new island of 70 open reading frames, which is integrated in the tRNA-arg (PA0256) 3′ end. This new island has genes involved in a type I restriction modification system. Many bacteriophages were detected in all of the strains, most of them having genes involved in phage biogenesis and heavy-metal resistance. Strains Pa58 and Pa84 presented a CRISPR-Cas (clustered regularly interspaced short palindromic repeats and CRISPR-associated genes) array in their chromosomes. All of the strains showed genes of four efflux pump systems, MexAB, MexCD, MexEF, and MexXY. Strain Pa58 also has genes of the AcrAB efflux pump from Enterobacter cloacae. All of the strains carried the OprD, OprJ, and OprM porins, the β-lactams OXA-2 and OXA-50, and the genes fosA and aph(3′). GyrA presented a mutation at amino acid position 83 (T → I), conferring resistance to fluoroquinolones. Strains Pa58, Pa124, and Pa127 presented new variants of class 1 integrons, namely, In1402 (http://integrall.bio.ua.pt/?acc=CP021774), In1403 and In1404 (http://integrall.bio.ua.pt/?acc=CP021775), and In1408 (http://integrall.bio.ua.pt/?acc=CP022000), which present the resistance genes aadA1, aadA6, OXA-2, and sul1. All of the strains presented type IV secretion system genes, as well as type III secretion system (exoU, exoS, exoT, and exoY) genes.

Accession number(s).

These whole-genome projects have been deposited in GenBank under the accession numbers listed in Table 1. The BioProject accession number is PRJNA389181.
  12 in total

1.  Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

Authors:  A-P Magiorakos; A Srinivasan; R B Carey; Y Carmeli; M E Falagas; C G Giske; S Harbarth; J F Hindler; G Kahlmeter; B Olsson-Liljequist; D L Paterson; L B Rice; J Stelling; M J Struelens; A Vatopoulos; J T Weber; D L Monnet
Journal:  Clin Microbiol Infect       Date:  2011-07-27       Impact factor: 8.067

2.  Nonhybrid, finished microbial genome assemblies from long-read SMRT sequencing data.

Authors:  Chen-Shan Chin; David H Alexander; Patrick Marks; Aaron A Klammer; James Drake; Cheryl Heiner; Alicia Clum; Alex Copeland; John Huddleston; Evan E Eichler; Stephen W Turner; Jonas Korlach
Journal:  Nat Methods       Date:  2013-05-05       Impact factor: 28.547

3.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

4.  Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa.

Authors:  X Liang; X Q Pham; M V Olson; S Lory
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

5.  Large genome rearrangements discovered by the detailed analysis of 21 Pseudomonas aeruginosa clone C isolates found in environment and disease habitats.

Authors:  U Römling; K D Schmidt; B Tümmler
Journal:  J Mol Biol       Date:  1997-08-22       Impact factor: 5.469

6.  INTEGRALL: a database and search engine for integrons, integrases and gene cassettes.

Authors:  Alexandra Moura; Mário Soares; Carolina Pereira; Nuno Leitão; Isabel Henriques; António Correia
Journal:  Bioinformatics       Date:  2009-02-19       Impact factor: 6.937

7.  Sequence analysis of the mobile genome island pKLC102 of Pseudomonas aeruginosa C.

Authors:  Jens Klockgether; Oleg Reva; Karen Larbig; Burkhard Tümmler
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

8.  Genetic and phenotypic characterization of a Pseudomonas aeruginosa population with high frequency of genomic islands.

Authors:  Rosario Morales-Espinosa; Gloria Soberón-Chávez; Gabriela Delgado-Sapién; Luisa Sandner-Miranda; José L Méndez; Gerardo González-Valencia; Alejandro Cravioto
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

9.  Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico City.

Authors:  Rosario Morales-Espinosa; Gabriela Delgado; Luis F Espinosa; Dassaev Isselo; José L Méndez; Cristina Rodriguez; Guadalupe Miranda; Alejandro Cravioto
Journal:  Front Microbiol       Date:  2017-03-01       Impact factor: 5.640

10.  IslandViewer 3: more flexible, interactive genomic island discovery, visualization and analysis.

Authors:  Bhavjinder K Dhillon; Matthew R Laird; Julie A Shay; Geoffrey L Winsor; Raymond Lo; Fazmin Nizam; Sheldon K Pereira; Nicholas Waglechner; Andrew G McArthur; Morgan G I Langille; Fiona S L Brinkman
Journal:  Nucleic Acids Res       Date:  2015-04-27       Impact factor: 16.971

View more
  2 in total

1.  Novel Chromosome-Borne Accessory Genetic Elements Carrying Multiple Antibiotic Resistance Genes in Pseudomonas aeruginosa.

Authors:  Ting Yu; Huiying Yang; Jun Li; Fangzhou Chen; Lingfei Hu; Ying Jing; Xinhua Luo; Zhe Yin; Mingxiang Zou; Dongsheng Zhou
Journal:  Front Cell Infect Microbiol       Date:  2021-03-18       Impact factor: 5.293

2.  Characterization of antimicrobial resistance mechanisms in carbapenem-resistant Pseudomonas aeruginosa carrying IMP variants recovered from a Mexican Hospital.

Authors:  Alma López-García; Rosa Del Carmen Rocha-Gracia; Elena Bello-López; Claudia Juárez-Zelocualtecalt; Yolanda Sáenz; Miguel Castañeda-Lucio; Liliana López-Pliego; María Cristina González-Vázquez; Carmen Torres; Teolincacihuatl Ayala-Nuñez; Guadalupe Jiménez-Flores; Margarita María de la Paz Arenas-Hernández; Patricia Lozano-Zarain
Journal:  Infect Drug Resist       Date:  2018-09-20       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.